Pluristem Therapeutics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
110.87 M |
Public Float |
103.16 M |
Pluristem Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.32 |
Market Cap |
$88.22 M |
Shares Outstanding |
149.74 M |
Public Float |
102.6 M |
Address |
MATAM Advanced Technology Park Haifa HA 31905 Israel |
Employees | - |
Website | http://www.pluristem.com |
Updated | 07/08/2019 |
Pluristem Therapeutics, Inc. is a biotechnology company, which engages in the provision of cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others. |